US09247X1019 - Common Stock
2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue YoY % growth | 19.374B 19.56% | 17.873B -7.75% | 17.859B -0.08% | 20.359B 14.00% | |||||||
EBITDA YoY % growth | 8.139B 19.55% | 6.9B -15.22% | 6.763B -1.99% | 8.384B 23.97% | |||||||
EBIT YoY % growth | 7.724B 19.75% | 6.482B -16.08% | 6.336B -2.25% | 7.803B 23.15% | |||||||
Operating Margin | 39.87% | 36.27% | 35.48% | 38.33% | |||||||
EPS YoY % growth | 39.17 15.72% | 35.36 -9.73% | 37.78 6.84% | 41.39 9.56% |
All data in USD
Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
---|---|---|---|---|---|---|---|---|---|---|---|
EPS Q2Q % growth | 10.01 7.91% | ||||||||||
Revenue Q2Q % growth | 4.892B 9.61% | N/A | N/A | N/A | N/A | ||||||
EBITDA Q2Q % growth | 2.026B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
EBIT Q2Q % growth | 1.847B 14.15% | N/A | N/A | N/A | N/A |
All data in USD
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q1 2024 Q2Q % growth | 9.81 23.71% | 9.44 | 0.37 | 3.94% |
Q4 2023 Q2Q % growth | 9.66 8.17% | 8.92 | 0.74 | 8.24% |
Q3 2023 Q2Q % growth | 10.91 14.24% | 8.34 | 2.57 | 30.81% |
Q2 2023 Q2Q % growth | 9.28 26.09% | 8.55 | 0.73 | 8.55% |
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q1 2024 Q2Q % growth | 4.728B 11.43% | 4.722B | 6M | 0.13% |
Q4 2023 Q2Q % growth | 4.631B 6.78% | 4.674B | -43M | -0.92% |
Q3 2023 Q2Q % growth | 4.522B 4.89% | 4.589B | -67M | -1.46% |
Q2 2023 Q2Q % growth | 4.463B -1.39% | 4.511B | -48M | -1.06% |
Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
---|---|---|---|---|
EPS | 2.07% | 2.63% | 1.99% | 2.38% |
Revenue | 0.47% | 0.4% | 0.44% | 0.56% |